MacDonald James J. 4
4 · Sana Biotechnology, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
MacDonald James J.
See Remarks
Transactions
- Conversion
Common Stock
2021-02-08+93,750→ 428,750 total - Conversion
Common Stock
2021-02-08+7,812→ 7,812 total(indirect: By Trust) - Conversion
Series A-1 Convertible Preferred Stock
2021-02-08−93,750→ 0 total→ Common Stock (93,750 underlying) - Conversion
Series B Convertible Preferred Stock
2021-02-08−7,812→ 0 total(indirect: By Trust)→ Common Stock (7,812 underlying)
Holdings
- 125,000(indirect: By Trust)
Common Stock
- 125,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
- [F2]The expiration date is not relevant to the conversion of these securities.